12/04/2008
New Criteria Identify Additional Patients With Cancer Who Benefit From Liver Transplantation (Medical News Today)
A substantial number of patients with hepatocellular carcinoma (HCC) who exceed the Milan criteria (which are currently used to select transplant candidates) could also be good candidates for successful transplantation, according to findings of a web-based survey of 1112 patients, which is published in an Article early Online and in the January edition of The Lancet Oncology.
MORE INFO
|
12/04/2008
Stem cell heart surgery may spell the end for transplantation (New Kerala)
London, Dec 4 : British scientists have developed a new technique that can rebuild a severely damaged heart, and one day, might replace the need for transplantation.
MORE INFO
|
12/04/2008
Children do well 5 years after liver transplant (Reuters via Yahoo! News)
New research indicates that most children who are 5-year survivors of liver transplantation have good graft function; however, chronic medical conditions and complications affecting other organs are common in this patient population.
MORE INFO
|
12/04/2008
Stem cell therapy, end of transplants? (The Times of India)
LONDON: British scientists have developed a new technique that can rebuild a severely damaged heart, and one day, might replace the need for transplantation.
MORE INFO
|
12/04/2008
Osiris Completes Enrollment in First Worldwide Phase III Stem Cell Trial (Centre Daily Times)
Osiris Therapeutics, Inc . (NASDAQ:OSIR) announced today that it has completed patient enrollment in its Phase III pivotal trial evaluating Prochymal for the treatment of steroid-refractory acute Graft versus Host Disease (GvHD), a life threatening complication of bone marrow transplantation. Prochymal is a proprietary formulation of adult mesenchymal stem cells (MSCs) designed to provide ...
MORE INFO
|
12/04/2008
Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations (PR Newswire via Yahoo! Finance)
Biopharmaceutical company Kiadis Pharma announces today that it has successfully completed treatment of the last patient on its ATIR phase I/II clinical trial. ATIR, a donor lymphocyte cell based product, is under development to prevent acute Graft versus Host Disease and allow early immune reconstitution following a mismatched bone marrow transplantation.
MORE INFO
|
12/04/2008
Osiris Completes Enrollment in First Worldwide Phase III Stem Cell Trial (Business Wire via Yahoo! Finance)
COLUMBIA, Md.----Osiris Therapeutics, Inc. announced today that it has completed patient enrollment in its Phase III pivotal trial evaluating Prochymal for the treatment of steroid-refractory acute Graft versus Host Disease , a life threatening complication of bone marrow transplantation.
MORE INFO
|
12/03/2008
CORRESPONDENCE: Osteosarcoma Derived from Donor Stem Cells Carrying the Norrie's Disease Gene (New England Journal of Medicine)
To the Editor: There have been few reports of osteosarcoma after allogeneic bone marrow transplantation.1 We report the development of ...
MORE INFO
|
12/01/2008
Media Advisory: BC Celebrates 20 Years of Heart Transplantation (CCNMatthews via Yahoo! Finance)
VANCOUVER, BRITISH COLUMBIA-- - Media representatives are invited to attend a press conference on Tuesday, December 2. Physicians, heart transplant recipients and representatives from the Province and BC Transplant will gather to celebrate the 20th Anniversary of Heart Transplantation in British Columbia.
MORE INFO
|
12/04/2008
Mom's Cells Prime Fetal Immune System (HealthDay via Yahoo! News)
THURSDAY, Dec. 4 (HealthDay News) -- During pregnancy, many of the mother's cells enter the fetus and produce immune cells that prevent the growing baby from rejecting its mother, new research shows.
MORE INFO
|